Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK; INBUILD Trial Investigators. Flaherty KR, et al. Among authors: richeldi l. N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29. N Engl J Med. 2019. PMID: 31566307 Clinical Trial.
Rifabutin for treating pulmonary tuberculosis.
Davies G, Cerri S, Richeldi L. Davies G, et al. Among authors: richeldi l. Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD005159. doi: 10.1002/14651858.CD005159.pub2. Cochrane Database Syst Rev. 2007. PMID: 17943842 Free PMC article. Review.
Non-steroid agents for idiopathic pulmonary fibrosis.
Spagnolo P, Del Giovane C, Luppi F, Cerri S, Balduzzi S, Walters EH, D'Amico R, Richeldi L. Spagnolo P, et al. Among authors: richeldi l. Cochrane Database Syst Rev. 2010 Sep 8;(9):CD003134. doi: 10.1002/14651858.CD003134.pub2. Cochrane Database Syst Rev. 2010. PMID: 20824834 Review.
Emerging drugs for idiopathic pulmonary fibrosis.
Selman M, Pardo A, Richeldi L, Cerri S. Selman M, et al. Among authors: richeldi l. Expert Opin Emerg Drugs. 2011 Jun;16(2):341-62. doi: 10.1517/14728214.2011.565049. Epub 2011 Mar 17. Expert Opin Emerg Drugs. 2011. PMID: 21410428 Free article. Review.
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Richeldi L, Costabel U, Selman M, Kim DS, Hansell DM, Nicholson AG, Brown KK, Flaherty KR, Noble PW, Raghu G, Brun M, Gupta A, Juhel N, Klüglich M, du Bois RM. Richeldi L, et al. N Engl J Med. 2011 Sep 22;365(12):1079-87. doi: 10.1056/NEJMoa1103690. N Engl J Med. 2011. PMID: 21992121 Free article. Clinical Trial.
Management of idiopathic pulmonary fibrosis.
Cerri S, Spagnolo P, Luppi F, Richeldi L. Cerri S, et al. Among authors: richeldi l. Clin Chest Med. 2012 Mar;33(1):85-94. doi: 10.1016/j.ccm.2011.11.005. Epub 2011 Dec 28. Clin Chest Med. 2012. PMID: 22365248 Free article. Review.
The big clinical trials in idiopathic pulmonary fibrosis.
Luppi F, Spagnolo P, Cerri S, Richeldi L. Luppi F, et al. Among authors: richeldi l. Curr Opin Pulm Med. 2012 Sep;18(5):428-32. doi: 10.1097/MCP.0b013e3283567ff9. Curr Opin Pulm Med. 2012. PMID: 22759771 Review.
399 results